Innovations for Tackling Tuberculosis in the Time of COVID-19: Proceedings of a Workshop (2022)
Chapter: Appendix C: Workshop Agenda
Visit
NAP.edu/10766
to get more information about this book, to buy it in print, or to
download it as a free PDF.
Previous Chapter:
Appendix B: Workshop Statement of Task
Appendix C
Suggested Citation:
"Appendix C: Workshop Agenda." National Academies of Sciences, Engineering, and Medicine. 2022. Innovations for Tackling Tuberculosis in the Time of COVID-19: Proceedings of a Workshop. Washington, DC: The National Academies Press.
doi: 10.17226/26530.
Appendix C
Workshop Agenda
WORKSHOP PART 1
THURSDAY, JULY 22, 2021
11:00 AM–1:00 PM ET
| 11:00 AM | Welcome Remarks, Workshop Overview, and Goals |
| Kenneth Castro, workshop co-chair | |
| Gail Cassell, workshop co-chair | |
| 11:05 AM | Opening Addresses: Current Status and Urgency of Ending TB Around the Globe |
| Jim Yong Kim (Global Infrastructure Partners) | |
| Salmaan Keshavjee (Harvard Medical School) | |
| Eric Rubin (New England Journal of Medicine) |
| Moderator: Lucica Ditiu | |
| 11:30 AM | Diagnostics |
| Soumya Swaminathan (World Health Organization) | |
| 11:40 AM | Vaccines and Therapeutics |
| Emilio Emini (Bill & Melinda Gates Foundation) |
Suggested Citation:
"Appendix C: Workshop Agenda." National Academies of Sciences, Engineering, and Medicine. 2022. Innovations for Tackling Tuberculosis in the Time of COVID-19: Proceedings of a Workshop. Washington, DC: The National Academies Press.
doi: 10.17226/26530.
| 11:50 AM | Critical Need for New Business Models |
| Kevin Outterson (Boston University School of Law) | |
| 12:00 PM | Discussion (50 min) |
| 12:55 PM | Wrap-up and Adjourn |
| Gail Cassell, workshop co-chair | |
| Kenneth Castro, workshop co-chair |
WORKSHOP—PART TWO
TUESDAY, SEPTEMBER 14, 2021
11:00 AM–2:30 PM ET
| 11:00 AM | Welcome and Workshop Goals |
| Peter Daszak, Chair, Forum on Microbial Threats, National Academy of Medicine; President, EcoHealth Alliance | |
| Lucica Ditiu, moderator, Stop TB Partnership | |
| 11:05 AM | Sponsor Remarks |
| Jennifer Adams, Senior Deputy Assistant Administrator, Bureau for Global Health, United States Agency for International Development | |
| 11:20 AM | Building a Tuberculosis-Free World: Progress Update |
| Eric Goosby (University of California, San Francisco) | |
| 15 min Q&A | |
| Realities of Multidrug-Resistant TB and Challenges for TB Control | |
| Matteo Zignol (World Health Organization) | |
| 15 min Q&A |
Suggested Citation:
"Appendix C: Workshop Agenda." National Academies of Sciences, Engineering, and Medicine. 2022. Innovations for Tackling Tuberculosis in the Time of COVID-19: Proceedings of a Workshop. Washington, DC: The National Academies Press.
doi: 10.17226/26530.
| 12:15 PM | Rapid Acceleration of Diagnostics: The COVID-19 Experience |
| Matthew McMahon (Director, Small Business Education and Entrepreneurial Development, NIH) | |
| 15 min Q&A | |
| 12:45 PM | Panel Discussion on Diagnostic Advances |
| Point-of-Care Molecular Platform for Diagnosis of TB and Other Infectious Respiratory Diseases | |
| Morten Ruhwald (FIND, the global alliance for diagnostics) | |
| Platform Technologies for Detection of Multiple Agents | |
| Zvi Marom (BATM) and Eran Zahavy (BATM) | |
| Improving X-Ray Accessibility | |
| Luan Vo (Friends for International Tuberculosis Relief) | |
| Implementation Challenges with New TB Diagnostics | |
| Kaiser Shen (USAID) | |
| 1:15 PM | Enhancing Adherence, Infection Control Capacities, and Cost-Effectiveness |
| Expansion and Improvements to Contact Tracing and Engagement: Mobile or Digital Platforms from the COVID-19 Pandemic | |
| Aamir Khan (IRD) | |
| Telehealth and Digital Adherence Technologies | |
| Bruce Thomas (The Arcady Group) | |
| Innovative Strategies to Share the Costs of Investments in Health Care Systems by Partnering with Other Disease Burdens in LMICs | |
| Monique K. Mansoura (MITRE) |
Suggested Citation:
"Appendix C: Workshop Agenda." National Academies of Sciences, Engineering, and Medicine. 2022. Innovations for Tackling Tuberculosis in the Time of COVID-19: Proceedings of a Workshop. Washington, DC: The National Academies Press.
doi: 10.17226/26530.
| Infection Prevention | |
| Edward Nardell (Harvard Medical School, Brigham and Women’s Hospital) | |
| Management of Latent TB Infection: Gaps and Opportunities | |
| Gavin Churchyard (The Aurum Institute) | |
| 2:15 PM | Reflections on Session 1 |
| Lucica Ditiu | |
| 2:30 PM | Adjourn |
WORKSHOP PART 2
WEDNESDAY, SEPTEMBER 15, 2021
11:00 AM–2:30 PM ET
| 11:00 AM | Welcome and Session Goals |
| Kent Kester, moderator, Sanofi Pasteur | |
| 11:05 AM | Using Existing Tools and New Technologies |
| BCG Revaccination | |
| Alex Schmidt (Bill & Melinda Gates Medical Research Institute) | |
| Promising New Adjuvants and Late-Stage Clinical Development Vaccine Candidates | |
| Steve Reed (University of Washington; HDT Bio) | |
| How Host-Directed Therapies Can Change the Development Landscape | |
| Daniel Kalman (Emory University) | |
| Immune Mechanisms of Protection Against TB | |
| Rhea Coler (Seattle Children’s Hospital) | |
| 12:00 PM | Transforming Treatment Options |
| Charles Wells, moderator, Bill & Melinda Gates Medical Research Institute |
Suggested Citation:
"Appendix C: Workshop Agenda." National Academies of Sciences, Engineering, and Medicine. 2022. Innovations for Tackling Tuberculosis in the Time of COVID-19: Proceedings of a Workshop. Washington, DC: The National Academies Press.
doi: 10.17226/26530.
| The Key to Success for Developing a New Regimen to Advance TB Treatment: Lessons from TBTC Study 31 (S31/A5349) | |
| Payam Nahid (University of California, San Francisco) | |
| What It Takes to Roll Out a New Treatment Regimen: Lessons from Drug-Resistant TB | |
| Adrian Thomas (Johnson & Johnson) | |
| Norbert Ndjeka (National Department of Health, Republic of South Africa) | |
| Bringing Innovation to the Development of New Transformative TB Regimens | |
| David Hermann (Bill & Melinda Gates Foundation) | |
| Importance of Context-Specific Economic Analyses to Inform Future Program Design and Investment | |
| Anna Vassall (London School of Hygiene & Tropical Medicine) | |
| 1:00 PM | Expert Reflections and Discussion on Critical Elements for Implementation |
| Ezra Shimeles Tessera (TB Data, Impact Assessment and Communications Hub, USAID; John Snow, Inc.) | |
| Richard Chaisson (Johns Hopkins University School of Medicine and Bloomberg School of Public Health) | |
| 2:15 PM | Reflections on Session 2 |
| Kent Kester | |
| Charles Wells | |
| 2:30 PM | Adjourn |
WORKSHOP PART 2
THURSDAY, SEPTEMBER 16, 2021
11:00 AM–2:30 PM ET
| 11:00 AM | Welcome: Session Goals and Bold Moves |
| Peter Sands, moderator, The Global Fund |
Suggested Citation:
"Appendix C: Workshop Agenda." National Academies of Sciences, Engineering, and Medicine. 2022. Innovations for Tackling Tuberculosis in the Time of COVID-19: Proceedings of a Workshop. Washington, DC: The National Academies Press.
doi: 10.17226/26530.
| 11:10 AM | Opening Remarks |
| Victor Dzau, President, National Academy of Medicine | |
| 11:15 AM | A Place for TB in the Pandemic Preparedness Agenda |
| Tharman Shanmugaratnam, Senior Minister, Singapore, and co-chair, G20 High-Level Independent Panel on Financing the Global Commons for Pandemic Preparedness and Response | |
| 11:50 AM | Achieving Synergy in Global Health Security Preparedness Against Respiratory Pathogens: Recognition of TB as a Leading Killer |
| Peter Sands, moderator | |
| John Bell (University of Oxford) | |
| Bruce Gellin (The Rockefeller Foundation) | |
| Rebecca Katz (Georgetown University, Center for Global Health Science and Security) | |
| Michael Callahan (Massachusetts General Hospital; United Therapeutics) | |
| 1:05 PM | Making the Case for Financing TB Elimination |
| Margaret Hamburg, moderator, Nuclear Threats Initiative | |
| The Cost of Failing to Achieve the End TB Targets: A Full Economic Analysis | |
| Michael Reid (University of California, San Francisco) | |
| Why TB Is One of the Best Investments on the SDG Agenda | |
| Bjorn Lomborg (Copenhagen Consensus Center) | |
| Smart Investments in Ending TB | |
| Mark Dybul (Georgetown University; Enochian BioSciences) | |
| Implications for TB from the High-Level Independent Panel on Financing the Global Commons for Pandemic Preparedness and Response | |
| Amanda Glassman (Center for Global Development) |
Suggested Citation:
"Appendix C: Workshop Agenda." National Academies of Sciences, Engineering, and Medicine. 2022. Innovations for Tackling Tuberculosis in the Time of COVID-19: Proceedings of a Workshop. Washington, DC: The National Academies Press.
doi: 10.17226/26530.
| 2:00 PM | Closing Remarks |
| Margaret Hamburg | |
| Gail Cassell, workshop co-chair | |
| Kenneth Castro, workshop co-chair | |
| 2:30 PM | Adjourn |
Suggested Citation:
"Appendix C: Workshop Agenda." National Academies of Sciences, Engineering, and Medicine. 2022. Innovations for Tackling Tuberculosis in the Time of COVID-19: Proceedings of a Workshop. Washington, DC: The National Academies Press.
doi: 10.17226/26530.
This page intentionally left blank.
Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.